BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 37495945)

  • 1. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.
    Fan YJ; Li JC; Zhu DM; Zhu HL; Zhao Y; Zhu XB; Wu G; Bai TT
    BMC Surg; 2023 Jul; 23(1):209. PubMed ID: 37495945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary treatment for operable primary breast cancer.
    Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis.
    Petousis S; Christidis P; Margioula-Siarkou C; Liberis A; Vavoulidis E; Margioula-Siarkou G; Vatopoulou A; Papanikolaou A; Mavromatidis G; Dinas K
    Arch Gynecol Obstet; 2022 Oct; 306(4):1221-1234. PubMed ID: 35249123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.
    Huang TW; Kuo KN; Chen KH; Chen C; Hou WH; Lee WH; Chao TY; Tsai JT; Su CM; Huang MT; Tam KW
    Int J Surg; 2016 Oct; 34():73-80. PubMed ID: 27562691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Early-Stage Breast Cancer Patients with Sentinel Lymph Node Metastasis with and without Completion Axillary Lymph Node Dissection: A Systematic Review and Meta-Analysis.
    Heiranizadeh N; Rafiei Shahamabadi M; Dehghan HR; Jafari-Nedooshan J; Kargar S; Zare M; Amooei A; Shiryazdi SM; Broomand MA; Moravej MT; Sadri Z
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2561-2571. PubMed ID: 36037108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy.
    Chun JW; Kang E; Kim HK; Lee HB; Moon HG; Lee JW; Han W
    Ann Surg Oncol; 2024 May; 31(5):3168-3176. PubMed ID: 38368292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.
    Zheng Q; Luo H; Xia W; Lu Q; Jiang K; Hong R; Xu F; Wang S
    Breast Cancer Res Treat; 2022 Dec; 196(3):613-622. PubMed ID: 36207619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.
    Wang Z; Wu LC; Chen JQ
    Breast Cancer Res Treat; 2011 Oct; 129(3):675-89. PubMed ID: 21743996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is repeat sentinel lymph node biopsy possible for surgical axillary staging among patients with ipsilateral breast tumor recurrence?
    Lu X; He M; Yu L; Gou Z
    Cancer; 2023 May; 129(10):1492-1501. PubMed ID: 36807239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and oncological safety of sentinel node biopsy in breast cancer patients with a local recurrence.
    Biglia N; Bounous VE; Gallo M; Fuso L; Sgro LG; Maggiorotto F; Ponzone R
    Breast; 2018 Oct; 41():8-13. PubMed ID: 29933180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary Lymph Node Dissection is Associated with Improved Survival Among Men with Invasive Breast Cancer and Sentinel Node Metastasis.
    Chung SH; de Geus SWL; Shewmaker G; Romatoski KS; Drake FT; Ko NY; Merrill AL; Hirsch AE; Tseng JF; Sachs TE; Cassidy MR
    Ann Surg Oncol; 2023 Sep; 30(9):5610-5618. PubMed ID: 37204557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial.
    Canavese G; Bruzzi P; Catturich A; Tomei D; Carli F; Garrone E; Spinaci S; Lacopo F; Tinterri C; Dozin B
    Ann Surg Oncol; 2016 Aug; 23(8):2494-500. PubMed ID: 26975739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary Management in Women with Early Breast Cancer and Limited Sentinel Node Metastasis: A Systematic Review and Metaanalysis of Real-World Evidence in the Post-ACOSOG Z0011 Era.
    Huang TW; Su CM; Tam KW
    Ann Surg Oncol; 2021 Feb; 28(2):920-929. PubMed ID: 32705512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
    Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
    Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal.
    Cebrecos I; Mension E; Alonso I; Castillo H; Sanfeliu E; Vidal-Sicart S; Ganau S; Vidal M; Schettini F
    Ann Surg Oncol; 2023 Aug; 30(8):4657-4668. PubMed ID: 36809608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Axillary Lymph Node Dissection be Omitted in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes Undergoing Mastectomy? A Systematic Review and Meta-Analysis of Real-World Evidence.
    Chen F; Li X; Lin X; Chen L; Lin Z; Wu H; Chen J
    World J Surg; 2023 Oct; 47(10):2446-2456. PubMed ID: 37249632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axilla lymph node dissection can be safely omitted in patients with 1-2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis.
    Gao W; Lu S; Zeng Y; Chen X; Shen K
    Breast Cancer Res Treat; 2022 Nov; 196(1):129-141. PubMed ID: 36076127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary lymph node dissection versus sentinel lymph node biopsy alone for early breast cancer with sentinel node metastasis: A meta-analysis.
    Li CZ; Zhang P; Li RW; Wu CT; Zhang XP; Zhu HC
    Eur J Surg Oncol; 2015 Aug; 41(8):958-66. PubMed ID: 26054706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.